GR82226B - - Google Patents
Info
- Publication number
- GR82226B GR82226B GR75407A GR840175407A GR82226B GR 82226 B GR82226 B GR 82226B GR 75407 A GR75407 A GR 75407A GR 840175407 A GR840175407 A GR 840175407A GR 82226 B GR82226 B GR 82226B
- Authority
- GR
- Greece
- Prior art keywords
- hydrogen
- zero
- guanidinothiazol
- 6alkanoyl
- histamine
- Prior art date
Links
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 3
- 239000001257 hydrogen Substances 0.000 abstract 3
- 229910052739 hydrogen Inorganic materials 0.000 abstract 3
- -1 2-guanidinothiazol-4-yl Chemical group 0.000 abstract 2
- 125000001140 1,4-phenylene group Chemical group [H]C1=C([H])C([*:2])=C([H])C([H])=C1[*:1] 0.000 abstract 1
- 125000000339 4-pyridyl group Chemical group N1=C([H])C([H])=C([*])C([H])=C1[H] 0.000 abstract 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 abstract 1
- 239000005864 Sulphur Substances 0.000 abstract 1
- 125000000217 alkyl group Chemical group 0.000 abstract 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 239000003485 histamine H2 receptor antagonist Substances 0.000 abstract 1
- 239000000543 intermediate Substances 0.000 abstract 1
- 125000000325 methylidene group Chemical group [H]C([H])=* 0.000 abstract 1
- 239000001301 oxygen Substances 0.000 abstract 1
- 229910052760 oxygen Inorganic materials 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 125000000547 substituted alkyl group Chemical group 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/47—One nitrogen atom and one oxygen or sulfur atom, e.g. cytosine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/48—Two nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Steroid Compounds (AREA)
- Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB838320505A GB8320505D0 (en) | 1983-07-29 | 1983-07-29 | Chemical compounds |
Publications (1)
Publication Number | Publication Date |
---|---|
GR82226B true GR82226B (el) | 1984-12-13 |
Family
ID=10546495
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GR75407A GR82226B (el) | 1983-07-29 | 1984-07-23 |
Country Status (21)
Country | Link |
---|---|
EP (1) | EP0134096B1 (el) |
JP (1) | JPS6051179A (el) |
KR (1) | KR850001174A (el) |
AT (1) | ATE40552T1 (el) |
AU (1) | AU564650B2 (el) |
CA (1) | CA1261831A (el) |
CS (1) | CS244448B2 (el) |
DD (1) | DD216933A5 (el) |
DE (1) | DE3476541D1 (el) |
DK (1) | DK368284A (el) |
ES (1) | ES534620A0 (el) |
FI (1) | FI842976L (el) |
GB (1) | GB8320505D0 (el) |
GR (1) | GR82226B (el) |
HU (1) | HUT34743A (el) |
IL (1) | IL72491A0 (el) |
JO (1) | JO1327B1 (el) |
NO (1) | NO843043L (el) |
PT (1) | PT78977B (el) |
ZA (1) | ZA845820B (el) |
ZW (1) | ZW11584A1 (el) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4772704A (en) * | 1983-09-21 | 1988-09-20 | Bristol-Myers Company | 2,5-disubstituted-4(3H)-pyrimidones having histamine H2 -receptor antagonist activity |
GB8421427D0 (en) * | 1984-08-23 | 1984-09-26 | Smith Kline French Lab | Chemical compounds |
EP1761496A2 (en) * | 2004-03-31 | 2007-03-14 | Janssen Pharmaceutica N.V. | Non-imidazole heterocyclic compounds as histamine h3-receptor ligands |
KR101372941B1 (ko) | 2006-05-30 | 2014-03-14 | 얀센 파마슈티카 엔.브이. | 히스타민 h3 수용체 조절제로서의 치환된 피리딜 아미드 화합물 |
WO2009067401A1 (en) | 2007-11-20 | 2009-05-28 | Janssen Pharmaceutica N.V. | Cycloalkyloxy-and hetξrocycloalky- loxypyridine compounds as modulators of the histamine h3 receptor |
EP4196793A1 (en) | 2020-08-11 | 2023-06-21 | Université de Strasbourg | H2 blockers targeting liver macrophages for the prevention and treatment of liver disease and cancer |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IN151188B (el) * | 1978-02-13 | 1983-03-05 | Smith Kline French Lab | |
ZA793443B (en) * | 1978-07-26 | 1980-12-31 | Glaxo Group Ltd | Heterocyclic derivatives |
US4496567A (en) * | 1978-11-13 | 1985-01-29 | Smith Kline & French Laboratories Limited | Phenyl alkylaminopyrimidones |
US4521418A (en) * | 1979-02-21 | 1985-06-04 | Smith Kline & French Laboratories Limited | Guanidinothiazolyl derivatives |
ZW21281A1 (en) * | 1980-10-01 | 1981-11-18 | Smith Kline French Lab | Amine derivatives |
NZ202797A (en) * | 1981-12-28 | 1985-08-30 | Lilly Co Eli | Pyrimidine derivatives and pharmaceutical compositions |
-
1983
- 1983-07-29 GB GB838320505A patent/GB8320505D0/en active Pending
-
1984
- 1984-07-18 JO JO19841327A patent/JO1327B1/en active
- 1984-07-23 GR GR75407A patent/GR82226B/el unknown
- 1984-07-24 CA CA000459505A patent/CA1261831A/en not_active Expired
- 1984-07-24 AU AU30991/84A patent/AU564650B2/en not_active Ceased
- 1984-07-25 DE DE8484305045T patent/DE3476541D1/de not_active Expired
- 1984-07-25 PT PT78977A patent/PT78977B/pt unknown
- 1984-07-25 EP EP84305045A patent/EP0134096B1/en not_active Expired
- 1984-07-25 AT AT84305045T patent/ATE40552T1/de not_active IP Right Cessation
- 1984-07-25 IL IL72491A patent/IL72491A0/xx unknown
- 1984-07-26 ES ES534620A patent/ES534620A0/es active Granted
- 1984-07-26 FI FI842976A patent/FI842976L/fi not_active Application Discontinuation
- 1984-07-27 ZW ZW115/84A patent/ZW11584A1/xx unknown
- 1984-07-27 ZA ZA845820A patent/ZA845820B/xx unknown
- 1984-07-27 JP JP59158537A patent/JPS6051179A/ja active Pending
- 1984-07-27 NO NO843043A patent/NO843043L/no unknown
- 1984-07-27 KR KR1019840004474A patent/KR850001174A/ko not_active Application Discontinuation
- 1984-07-27 DD DD84265728A patent/DD216933A5/de unknown
- 1984-07-27 CS CS845810A patent/CS244448B2/cs unknown
- 1984-07-27 DK DK368284A patent/DK368284A/da not_active Application Discontinuation
- 1984-07-27 HU HU842902A patent/HUT34743A/hu unknown
Also Published As
Publication number | Publication date |
---|---|
FI842976L (fi) | 1985-01-30 |
AU564650B2 (en) | 1987-08-20 |
ATE40552T1 (de) | 1989-02-15 |
JO1327B1 (en) | 1986-11-30 |
GB8320505D0 (en) | 1983-09-01 |
DE3476541D1 (de) | 1989-03-09 |
EP0134096B1 (en) | 1989-02-01 |
CS244448B2 (en) | 1986-07-17 |
DK368284D0 (da) | 1984-07-27 |
HUT34743A (en) | 1985-04-28 |
AU3099184A (en) | 1985-01-31 |
PT78977A (en) | 1984-08-01 |
FI842976A0 (fi) | 1984-07-26 |
CA1261831A (en) | 1989-09-26 |
NO843043L (no) | 1985-01-30 |
PT78977B (en) | 1986-06-05 |
DD216933A5 (de) | 1985-01-02 |
IL72491A0 (en) | 1984-11-30 |
EP0134096A2 (en) | 1985-03-13 |
ZA845820B (en) | 1985-06-26 |
ES8600254A1 (es) | 1985-09-16 |
KR850001174A (ko) | 1985-03-16 |
DK368284A (da) | 1985-01-30 |
CS581084A2 (en) | 1985-08-15 |
ES534620A0 (es) | 1985-09-16 |
EP0134096A3 (en) | 1985-12-18 |
JPS6051179A (ja) | 1985-03-22 |
ZW11584A1 (en) | 1985-04-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE3069408D1 (en) | 5-oxo- and 5-thioxoproline derivatives, process for their production and pharmaceutical compositions containing them | |
NO894349L (no) | Tienopyridin-type mevalonolaktoner. | |
CS581084A2 (en) | Zpusob vyroby aminopyrimidinonovych derivatu | |
EP0180298A3 (en) | Pyrimidine compounds | |
GR81941B (el) | ||
EP0143630A3 (en) | Chemical compounds | |
SE8303913L (sv) | Heterocykliska foreningar | |
ES8602764A1 (es) | Un procedimiento para preparar derivados de tiadiazina | |
IE56020B1 (en) | Dioxocyclobutene compounds | |
HUT39158A (en) | Process for preparing carbacyclines and pharmaceutical compositions containing such compounds | |
DE3163803D1 (en) | 2-methyl-5-thiazole-methylamine and carboxamide derivatives | |
ES8401966A1 (es) | Procedimiento para preparar las (2,3-dihidro(1,4-benzodioxin-2-il) alcoil) piperidin-4-il-(n-ciano-n'-r) guanidinas. | |
DE3070032D1 (en) | Aminoalkyl benzofuran derivatives, their production and compositions containing them | |
EP0140466A3 (en) | Pyrimidinone derivatives, process for their preparation, and their pharmaceutical use |